Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Use of Antiemetic Agents in Acute Gastroenteritis 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. Medicare pay-for-reporting effort draws fire from frustrated doctors 5. Debunking Myths in the US Healthcare System
Your Article Summary
Atypical Mycobacterial and Fungal Infections in Cystic Fibrosis
Seminars in Respiratory and Critical Care Medicine, 09/24/09
Whittaker LA et al. – Nontuberculous mycobacteria (NTM) and fungi are prevalent in the sputum of cystic fibrosis patients and are increasingly recognized to cause clinically significant disease. In both instances the organisms are ubiquitous within the environment making exposure common, although specific risk factors that contribute to active pulmonary infection have not been identified. A consistent and aggressive approach to screening for NTM and fungi within the cystic fibrosis airway is likely indicated, especially in the setting of clinical deterioration despite standard antipseudomonal therapies.
Related Articles
Vitamin D supplementation for cystic fibrosis
Cochrane Reviews, 10/28/09
Relevance Score: 69%
Genetic Risk Factor for Liver Disease for Patients With Cystic Fibrosis
Gastroenterology, 10/27/09
Relevance Score: 69%
Inspire Announces Presentation at the North American Cystic Fibrosis Conference and Provides Enrollment Update for Phase 3 Cystic Fibrosis Trial
Inspire, 10/16/09
Relevance Score: 69%
Pulmonary nocardiosis in cystic fibrosis
Journal of Cystic Fibrosis, 10/07/09
Relevance Score: 69%
Cystic fibrosis neutrophils have normal intrinsic reactive oxygen species generation
European Respiratory Journal, 10/23/09
Relevance Score: 68%
Today in Fungal Infections...keeping you current
Receive free subspecialty "5-minute updates" via email
Recognition, Diagnosis, and Treatment of Histoplasmosis Complicating Tumor Necrosis Factor Blocker Therapy
Clinical Infectious Diseases, 12/07/09
Silver enhances the in vitro antifungal activity of the saponin, CAY-1
Mycoses, 12/07/09
Administration of IL-23 engages innate and adaptive immune mechanisms during fungal infection
International Immunology, 12/07/09
Today in Pulm/Thoracic Infections...keeping you current
Receive free subspecialty "5-minute updates" via email
Linezolid in the Treatment of Multidrug-Resistant Tuberculosis
Clinical Infectious Diseases, 12/07/09
Disseminated nontuberculous infections with Mycobacterium genavense during sarcoidosis
European Respiratory Review, 12/07/09
4 Months of Rifampin Compared with 9 Months of Isoniazid for the Management of Latent Tuberculosis Infection: A Meta-analysis and Cost-Effectiveness Study That Focuses on Compliance and Liver Toxicity
Clinical Infectious Diseases, 12/07/09
Article Search
Sponsor


See Latest Articles


